Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell therapy for ocular disorders.

Leonard A Levin1, Robert Ritch, Julia E Richards

  • 1Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, 600 Highland Avenue, Madison, WI 53792-4673, USA.

Archives of Ophthalmology (Chicago, Ill. : 1960)
|April 14, 2004
PubMed
Summary

Ocular stem cell research offers new therapeutic avenues for blinding diseases by repopulating damaged eye tissues. This review summarizes advancements and applications in ocular stem cell therapy for various eye conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Splicing variants in MYRF cause partial loss of function in the retinal pigment epithelium leading to nanophthalmos.

JCI insight·2026
Same author

From Observation to Prediction: Machine Learning Analysis of Progression of Visual loss in Nonarteritic Anterior Ischemic Optic Neuropathy.

American journal of ophthalmology·2026
Same author

Progression of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Occurs Early and Is Unassociated With Modifiable Risk Factors.

American journal of ophthalmology·2026
Same author

A Randomized Sham-Controlled Phase 2/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy.

Ophthalmology·2025
Same author

FOXP4 Variants Are Associated With Plateau Iris and Angle Closure Glaucoma.

Investigative ophthalmology & visual science·2025
Same author

Splicing variants in MYRF cause partial loss of function in the retinal pigment epithelium.

bioRxiv : the preprint server for biology·2025

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Cell Biology

Background:

  • Cell injury and degeneration are primary causes of many blinding diseases.
  • Traditional therapies focus on preventing initial cell damage or enhancing cellular resistance (cytoprotection).
  • Recent breakthroughs enable tissue repopulation using stem cells.

Purpose of the Study:

  • To present a comprehensive overview of current ocular stem cell research.
  • To explore the applications of stem cell therapy in treating blinding eye diseases.
  • To synthesize findings from an international conference on stem cells and glaucoma.

Main Methods:

  • Review of presentations and discussions from the "Stem Cells and Glaucoma" international conference (July 2002).
  • Synthesis of research from ophthalmologists, geneticists, immunologists, and developmental biologists.

Related Experiment Videos

  • Inclusion of studies utilizing both human and animal models.

    • Main Results:

    • Ocular stem cell research is rapidly advancing, offering potential for tissue regeneration.
    • Stem cell applications are being explored for various blinding conditions, including glaucoma.
    • Interdisciplinary collaboration is crucial for progress in the field.

    Conclusions:

    • Stem cell therapy represents a promising frontier in treating blinding eye diseases.
    • Further research and clinical translation are needed to fully realize the potential of ocular stem cells.
    • The integration of diverse scientific expertise accelerates innovation in regenerative ophthalmology.